Abstract: A functional health food containing Humulus japonicus extract as an active ingredient for preventing or improving metabolic disorders or for weight loss, a pharmaceutical composition containing Humulus japonicus extract as an active ingredient for preventing or treating metabolic disorders, a functional health food containing Humulus japonicus extract as an active ingredient for preventing or improving fatty liver, and a functional health food containing Humulus japonicus extract as an active ingredient for inhibiting the accumulation of visceral fat.
Abstract: A scaffold comprising an aligned fiber. The invention further relates to a scaffold comprising one or more electrospun fibers wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180? apart from each other. Methods for promoting differentiation of stem cells into osteoblasts, chondrocytes, ligament or tendon, the method comprising culturing the cells on the scaffold or aligned fiber in conditions suitable for the cell differentiation.
Abstract: This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.
Type:
Grant
Filed:
January 4, 2016
Date of Patent:
November 27, 2018
Assignee:
Melaleuca, Inc.
Inventors:
Alexander B. Rabovsky, Stephanie Y. Nielson
Abstract: The invention concerns the use of a cosmetic compound to improve hair strength, said cosmetic compound comprising as an active ingredient an extract of Balanites almonds.
Abstract: Solid, free-flowing, and substantially completely dissolvable preparations with high betalain content are presented. Most typically, the betalain profile of the preparations is near natural and includes betalains in an amount of between 10-40 wt %. As the preparations of the inventive subject matter maintain chemical stability and flowability over extended periods of time, it should be noted that the betalain preparations are now amenable to compounding in small and measured quantities. Furthermore, new biological activities of betalains are shown, and especially include significant induction of SIRT and reduction of serum triglyceride.
Type:
Grant
Filed:
July 2, 2015
Date of Patent:
November 13, 2018
Inventors:
Zbigniew Pietrzkowski, Wayne Carl Thresher
Abstract: Compositions for reducing skin aging are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
Type:
Grant
Filed:
April 30, 2014
Date of Patent:
November 13, 2018
Assignee:
Kimberly-Clark Worldwide, Inc.
Inventors:
Scott W. Wenzel, David J. Tyrrell, Alencia Vanay Grice, Stephanie VandeVen Teat
Abstract: Provided is a functional composition for preventing an Alzheimer's disease, in which the composition includes heat-treated salt that is heat-treated at 800° C. to 1200° C. as an effective component and other pharmaceutically or sitologically acceptable components. The composition can prevent an Alzheimer's disease by effectively blocking the cause path of an Alzheimer's disease in a human body.
Type:
Grant
Filed:
January 22, 2014
Date of Patent:
November 13, 2018
Assignee:
MOKPO NATIONAL UNIVERSITY INDUSTRY-ACADEMIA COOPERATION GROUP
Inventors:
Kyung Sik Ham, Jeong Yong Cho, Promyo Kitiong, Sun Young Park, JinRui Zhu
Abstract: Compositions include one or more unsaturated fatty acids and one or more nitric oxide releasing compounds. Methods for using such compositions can enhance cognitive function, reduce or prevent a decline of social interaction, reduce or prevent age-related behavioral changes, increase trainability, maintain optimal brain function, facilitate learning and memory, reduce memory loss, retard brain aging, prevent or treat strokes, and/or prevent or treat dementia in an animal. Preferably, the compositions are food compositions useful for enhancing cognitive function in humans and companion animals.
Abstract: The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
Abstract: The present invention is related to a formulation comprising Hedera helix, Pelargonium sidoides, and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
Abstract: Disclosed is a method for treating pruritus comprising topically applying a composition that includes effective amounts of an extract from Echinacea purpurea and an extract from Silybum marianum fruit to skin in need thereof, wherein topical application of the composition activates human cannabinoid receptor type 2 and inhibits fatty acid amide hydrolase activity in the skin and treats pruritus.
Abstract: A novel generation of biocidal materials is provided that do not pose any specific risks to the environment or health. The active substances and additives that make up the biocidal materials according to the invention originate from plants, agricultural products, and renewable resources, and are furthermore completely biodegradable. The various uses of said novel biocidal materials are also described.
Abstract: Implants having improved mechanical properties and/or degradation profiles, kits including such implants, and methods of producing and using the same.
Abstract: The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
Type:
Grant
Filed:
June 12, 2017
Date of Patent:
October 23, 2018
Assignee:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Stefania Bruno, Maria Beatriz Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
Abstract: The present invention relates to a process for the separation of a mixture of a protein and its reaction product with a polyalkylene glycol, comprising the steps: a) providing a mixture comprising the protein and the reaction product in a fluid, b) bringing the mixture of step a) into contact with a microporous cellulose acetate membrane with adsorption of the reaction product onto the cellulose acetate membrane, the protein not becoming adsorbed onto the cellulose acetate membrane, c) removal of the protein from the cellulose acetate membrane, and d) desorbing the reaction product from the cellulose acetate membrane, the reaction product being selected from the group comprising the protein which is mono- or polyfunctionalized by the polyalkylene glycol, or mixtures thereof.
Type:
Grant
Filed:
March 21, 2012
Date of Patent:
October 16, 2018
Assignee:
SARTORIUS STEDIM BIOTECH GMBH
Inventors:
Wolfgang Demmer, Louis Villain, Hans-Heinrich Hoerl
Abstract: The present disclosure provides methods of gaseous substrate fermentation comprising: adding gaseous substrate into an aqueous medium in a bioreactor. The methods of the present disclosure comprise: measuring cell density; adjusting input of gaseous substrate to increase cell density; changing hydrogen uptake.
Abstract: A method for obtaining proteins from native mixtures of materials is disclosed. In an embodiment, the method includes: A): providing a native mixture of materials from seeds having hard fragmentable hulls; B): comminuting the mixture of materials; C): dispersing the comminuted mixture of materials with water; D): adjusting a pH of the pulp of step C) to an alkaline range pH>9.5; E): adding a water-soluble organic solvent alcohol to the pulp; F): separating off a solids phase from the pulp, which has a predominant fraction of the hulls, to form a hull-free pulp; G): shifting the pH of the hull-free pulp from step F) to a pH range of pH=4.5 to pH=7.2; and H): separating the hull-free pulp of step G) into a plurality of phases, wherein one of the plurality of phases is a protein concentrate phase.
Abstract: A composition that includes spray-dried yoghurt powder and at least one anionic surfactant and/or at least one fatty acid soap, may be used as a prebiotic for inhibiting the growth and/or the physiological activity of undesired skin bacteria and/or for obtaining desired skin bacteria. A prebiotically effective cosmetic composition includes: a) at least one fatty acid soap in a weight proportion of between 20 and 75 wt. %, preferably between 30 and 70 wt. %, particularly preferably between 40 and 65 wt. %, and in particular between 45 and 60 wt. %; and b) spray-dried yoghurt powder in a weight proportion of between 0.01 and 10 wt. %, preferably 0.02 and 7.5 wt. %, particularly preferably between 0.03 and 5 wt. %, and in particular between 0.05 and 3 wt. %, wherein the amounts relate to the total weight of the cosmetic composition.